Does Mirtazapine Cause Withdrawal Symptoms?
Yes, mirtazapine can cause withdrawal symptoms upon discontinuation, particularly when stopped abruptly, and should be tapered gradually to minimize this risk.
Evidence from FDA Drug Label
The FDA-approved prescribing information explicitly warns about discontinuation syndrome with mirtazapine 1. Abrupt cessation can lead to serious side effects including:
- Dizziness
- Sensory disturbances (paresthesia and electric shock sensations)
- Agitation and anxiety
- Confusion and irritability
- Headache and tremor
- Nausea, vomiting, and sweating
- Abnormal dreams
- Fatigue
- Seizures (in severe cases)
The FDA label specifically recommends gradual dose reduction rather than abrupt cessation 1.
Supporting Clinical Evidence
Withdrawal Symptom Profile
A comprehensive review of antidepressants found that withdrawal symptoms can be classified into 8 groups: influenza-like symptoms, psychic symptoms, gastrointestinal symptoms, sleep disorders, equilibrium disorders, sensory disturbances, extrapyramidal symptoms, and other symptoms 2. These characteristically appear 1-4 days after dose reduction or last administration.
Real-World Case Evidence
Case reports demonstrate clinically significant withdrawal syndromes:
A 53-year-old woman developed severe, recurrent panic attacks within 2 days of abruptly stopping mirtazapine 30mg after only 10 weeks of treatment. She experienced attacks every 1-2 hours for 5 days, with symptoms including palpitations, dyspnea, chest pain, dizziness, nausea, and fear of dying. Symptoms only resolved after restarting mirtazapine 3.
A 53-year-old man on mirtazapine 15mg for appetite stimulation experienced anxiousness, nausea, tremor, loss of appetite, and 8-pound weight loss within 48 hours of inadvertent discontinuation. Symptoms persisted for 14 days and resolved immediately upon restarting 4.
Guideline-Level Evidence
A 2019 Lancet Psychiatry systematic review found evidence from 17 randomized placebo-controlled trials (6,729 participants) demonstrating risk of withdrawal symptoms with antidepressants at discontinuation, including more adverse events on tapering compared to placebo 5. Patient reports consistently documented withdrawal symptoms following dose reduction and cessation 5.
Clinical Implications
Key Points:
- Withdrawal can occur even at low doses (15mg) and after relatively short treatment durations (10 weeks) 3, 4
- Symptom onset is typically rapid (24-96 hours after discontinuation)
- Symptoms can be severe and persist until medication is restarted or properly tapered
Common Pitfalls to Avoid:
- Never stop mirtazapine abruptly - even after short-term use or at low doses
- Don't assume lower doses are safe to stop suddenly - withdrawal has been documented at 15mg 4
- Don't dismiss patient-reported withdrawal symptoms - they can be clinically significant and affect quality of life
Recommended Approach:
When discontinuing mirtazapine:
- Implement gradual dose reduction (specific tapering schedule should be individualized based on dose, duration of treatment, and patient factors)
- Monitor closely during the first week after any dose reduction
- Educate patients about potential withdrawal symptoms before initiating treatment and when planning discontinuation 2
- Consider slower taper in patients on higher doses or longer treatment duration
The evidence consistently supports that mirtazapine carries a real risk of discontinuation syndrome that can significantly impact patient morbidity and quality of life if not properly managed through gradual tapering 1, 2, 3, 4.